Patent Assignment
Reel/Frame 061716/0613
Assignment of Assignor's Interest
Recorded: 2022-11-10
Pages: 8
Assignors
HUANG, JIAQI
Executed: 2022-10-24
YAO, YIHONG
Executed: 2022-10-24
ZHU, SHIGUI
Executed: 2022-10-24
YAO, XIN
Executed: 2022-10-24
JI, YUN
Executed: 2022-10-24
XUE, WEI
Executed: 2022-10-24
WEI, YUTIAN
Executed: 2022-10-24
CHEN, CHENG
Executed: 2022-10-24
ZHANG, CHAOCAN
Executed: 2022-10-24
Assignee
SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
BUILDING 3, NO.85 FALADI ROAD, PUDONG NEW DISTRICT, SHANGHAI, 201210, CHINA
Covered Property
(1)
Anti-Bcma Antibodies and Chimeric Antigen Receptors
Application:
17/924,410 →
Publication:
US 2023/0181640
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Apr 16, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067128/0044 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 67128 Frame: 44. Assignor(S) Hereby Confirms the Change of Name.
May 7, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067334/0083 →